Skip to main content

Anti-HIV and Antibacterial Activities of Novel 2-(3-Substituted-4-oxo-3,4-dihydroquinazolin-2-yl)-2,3-dihydrophthalazine-1,4-diones


In the present study, we have synthesized a series of novel 2-(3-substituted-4-oxo-3,4-dihydroquinazolin-2-yl)-2,3-dihydrophthalazine-1,4-diones by the reaction of 3-(substituted)-2-hydrazino-quinazoline-4(3H)-ones with phthalic anhydride. The starting material 3-(substituted)-2-hydrazino-quinazolin-4(3H)-ones were synthesized from various primary amines. All the synthesized compounds were screened for their antitubercular, anti-HIV and antibacterial activity against different gram positive and gram negative strains by agar dilution method. Among the test compounds, 2-(3-(4-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)-2,3-dihydrophthalazine-1,4-dione (QCT7) shown most potent antibacterial activity against E. coli, and S. aureus with the MIC of 3 µg/mL. The compound QCT7 exhibited the antitubercular activity with the MIC of 25 µg/mL and anti-HIV activity with the EC50 of 43.68 µM against HIV1 and HIV2 and offers potential lead for further optimization and development to new antitubercular and anti-HIV agents. The results obtained from this study confirm that the synthesized and biologically evaluated quinazolines showed promising antimicrobial, antitubercular and anti-HIV activities and are new scaffolds for antimicrobial activity.

This is a preview of subscription content, access via your institution.


  1. World Health Organization, Global Tuberculosis Report 2018, Geneva, Switzerland: World Health Organization, 2018.

    Google Scholar 

  2. Balcha, T.T., Skogmar, S., Sturegård, E., Björkman, P., Winqvist, N., Glob. Health Action, 2015, vol. 8, pp. 27 048–27 049.

    Article  Google Scholar 

  3. Reid, M.J. and Shah, N.S., Lancet Infect. Dis., 2009, vol. 9, p. 173.

    Article  PubMed  Google Scholar 

  4. World Health Organization Tuberculosis. Accessed March 17, 2019.

  5. Alagarsamy, V., Chitra, K., Saravanan, G., Solomon, V. R., Sulthana, M.T., and Narendhar, B., Eur. J. Med. Chem., 2018, vol. 151, pp. 628–685.

    CAS  Article  PubMed  Google Scholar 

  6. Hameed, A., Al-Rashida, M., Uroos, M., Ali, S.A., Ishtiaq, M., and Khan, K.M., Expert Opin.Ther. Pat., 2018, vol. 28, pp. 281–297.

    CAS  Article  PubMed  Google Scholar 

  7. Pavan, F.R., Da S Maia, P.I., Leite, S.R., Deflon, V.M., Batista, A.A., Sato, D.N., Franzblau, S.G., and Leite, C.Q., Eur. J. Med. Chem., 2010, vol. 45, pp. 1898–1905.

    CAS  Article  PubMed  Google Scholar 

  8. Güzel, O., Karali, N., and Salman. A., Bioorg. Med. Chem., 2008, vol. 16, pp. 8976–8987.

    CAS  Article  PubMed  Google Scholar 

  9. Karali, N., Gürsoy, A., Kemirli, F., Shvets, N., Kaynak, F.B., Ozbey, S., Kovalishyn, V., and Dimoglo, A., Bioorg. Med. Chem., 2007, vol. 15, pp. 5888–5904.

    CAS  Article  PubMed  Google Scholar 

  10. Sriram, D., Yogeeswari, P., Thirumurugan, R., and Pavana, R.K., J. Med. Chem., 2006, vol. 49, pp. 3448–3450.

    CAS  Article  PubMed  Google Scholar 

  11. Sriram, D., Yogeeswari, P., Dhakla, P., Senthilkumar, P., Banerjee, D., Manjashetty, T.H., Bioorg. Med. Chem. Lett., 2009, vol. 19, pp. 1152–1154.

    CAS  Article  PubMed  Google Scholar 

  12. Saripinar, E., Güzel, Y., Patat, S., Yildirim, I., Akçamur, Y., and Dimoglo, A.S., Arzneimittelforschung, 1996, vol. 46, pp. 824–828.

    CAS  PubMed  Google Scholar 

  13. Milczarska, B., Foks, H., Sokołowska, J., Janowiec, M., Zwolska, Z., and Rzejczyk, Z., Acta Pol. Pharm., 1999, vol. 56, pp. 121–126.

    CAS  PubMed  Google Scholar 

  14. Turan-Zitouni, G., Ozdemir, A., Kaplancikli, Z.A., Benkli, K., Chevallet, P., and Akalin, G., Eur. J. Med. Chem., 2008, vol. 43, pp. 981–985.

    CAS  Article  PubMed  Google Scholar 

  15. Peya, S.N., Smitha, S., Jyoti, M., and Sridhar, S.K., Acta Pharmaceutica, 2005, vol. 55, pp. 27–46.

    Google Scholar 

  16. Meunier. B., Acc. Chem. Res., 2008, vol. 41, pp. 69–77.

  17. Alagarsamy, V., Solomon, V.R., Sheorey, R.V., and Jayakumar. R., Chem. Biol. Drug. Des., 2009, vol. 73, pp. 471–479.

    CAS  Article  PubMed  Google Scholar 

  18. Alagarsamy, V., Appani, R., Sulthana, M.T., Narendar, B., and Solomon, V.R., J. Chilean Chem. Soc., 2016, vol. 61, pp. 2856–2860.

    CAS  Article  Google Scholar 

  19. Sheory, R.V., Thangathiruppathy, A., and Alagarsamy, V., Trop. J. Pharm Res., 2013, vol. 12, pp. 583–589.

    CAS  Article  Google Scholar 

  20. Alagarsamy V., Solomon V.R., and Dhanabal, K., Bioorg. Med. Chem., 2007, vol. 5, pp. 235–224.

    CAS  Article  Google Scholar 

  21. Gobinath, M., Subramanian, N., Alagarsamy, V., Nivedhitha S., and Solomon, V.R., Trop. J. Pharm. Res., 2015, vol. 14, pp. 271–277.

    CAS  Article  Google Scholar 

  22. Alagarsamy, V., Shankar, D., Murugan, M., Siddiqui, A.A., and Rajesh, R., Arch. Pharm. Chem. Life Sci., 2007 vol. 340, pp. 41–46.

    CAS  Article  Google Scholar 

  23. Alagarsamy, V., Giridhar, R., and Yadav, M.R., J. Pharm. Pharmacol., 2006, vol. 58, pp. 1249–1255.

    CAS  Article  PubMed  Google Scholar 

  24. Gobinath, M., Subramanian, N., Ruckmani, K., and Alagarsamy, V., Int. J. Drug Discov., 2011, vol. 2, pp. 642–647.

    CAS  Google Scholar 

  25. Sriram, D., Yogeeswari, P., Basha, J.S., Radha, D.R., and Nagaraja, V., Bioorg. Med. Chem., 2005, vol. 13, pp. 5774–5778.

    CAS  Article  PubMed  Google Scholar 

  26. Shanmugavelan, P., Nagarajan, S., Sathishkumar, M., Ponnuswamy, A., Yogeeswari, P., and Sriram, D., Bioorg. Med. Chem. Lett., 2011, vol. 21, pp. 7273–7276.

    CAS  Article  PubMed  Google Scholar 

  27. Kunes, J., Bazant, J., Pour, M., Waisser, K., Slosárek, M., and Janota, J., IL Farmaco, 2000, vol. 55, pp. 725–729.

    CAS  Article  PubMed  Google Scholar 

  28. Pauwels, R., Clercq, E. De., Desmyter, J., Balzarini, P., Goubabu, P., Herdesijin, P., Verhaughe, H., and Veputle, M. J., Virol. Methods, 1987, vol. 16, pp. 171–185.

    CAS  Article  Google Scholar 

  29. Barry, A., Antibiotics in Laboratory Medicine, 5th ed., Baltimore, MD: William Wilkins, 1991, vol. 1.

    Google Scholar 

  30. Peya, S.N., Sriram, D., Nath, G., and De Clercq, E., IL Farmaco, 1999, vol. 54, pp. 624–628.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to V. Alagarsamy.

Ethics declarations


This article does not contain studies that use humans and animals as objects of research.

Conflict of Interests

The authors declare no conflict of interest.

Additional information

Corresponding author: phone: +91 8455-230690; fax: +91 8455-230555.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sulthana, M.T., Chitra, K., Alagarsamy, V. et al. Anti-HIV and Antibacterial Activities of Novel 2-(3-Substituted-4-oxo-3,4-dihydroquinazolin-2-yl)-2,3-dihydrophthalazine-1,4-diones. Russ J Bioorg Chem 47, 112–121 (2021).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Quinazoline
  • antibacterial activity
  • antitubercular activity
  • anti-HIV activity